Evaluating whether interventions aimed at mimicking and/or preserving the ADNP signaling network could impede the progression of AD is also valuable, especially considering the subtle differences in GPCR expression observed between CT and AD [19]. This evidence concerns the gene ADNP and Alzheimer disease.